New 2025 AUA Guideline: Dr. Rachel Rubin Shows How Low-Dose Vaginal Estrogen Prevents UTIs, Relieves GSM Symptoms, and Protects Women’s Health

[madman]

BOXED WARNING

Dr. Rachel Rubin

Dr. Rachel Rubin outlines how simple, low-dose vaginal estrogen—backed by the 2025 AUA GSM guideline—can prevent recurrent UTIs, relieve symptoms, and save lives. A must-watch for providers treating menopausal patients.

 

[madman]

Thread 'FDA Expert Panel on Menopause and HRT Recommends Removing Black Box Labels'

Jul 17, 2025

This was a very important meeting with top experts that are trying to change guidelines. This FDA panel recently recommended removing the warning (“black box”) labels on menopausal HRT, citing potential benefits like reduced heart attack and bone fracture risk—and arguing the warning discourages appropriate use.

FDA Expert Panel on Menopause and Hormone Replacement Therapy for Women​

Hopefully, we will see progress in this field after the confusing and sometimes misleading conclusions of the WHI (“Women’s Health Initiative”), a large National Institutes of Health trial...

• madman
• menopause; hrt; estrogen; testosterone; health
• Replies: 16
• Forum: HRT in Women

 

[madman]

Thread 'AUA Guidelines on Genitourinary Syndrome of Menopause (GSM)'

Nov 12, 2025

Rachel Rubin, MD

• madman
• gsm; estradiol; vaginal health; menopause
• Replies: 3
• Forum: HRT in Women

 

[madman]

Thread 'FDA Removes Black Box Warning: What the New HRT Guidelines Mean for Women’s Health and HRT'

Nov 15, 2025

Dr. Rachel Rubin and Dr. Kelly Caspersen discuss with FDA Commissioner Dr. Marty Makary the significant impact of hormone replacement therapy (HRT) on women's health, particularly in the context of recent FDA changes to black box warnings. They explore the misconceptions surrounding HRT, the importance of education for both clinicians and patients, and the long-term health benefits of hormone therapy. The discussion emphasizes the need for accurate labeling, comprehensive care, and empowering women to make informed choices about their health...

• madman
• hrt; estrogen; fda; black box; women's health
• Replies: 3
• Forum: HRT in Women

 

[madman]

Thread 'New AUA Guideline Offers Clinicians a Practical Toolbox for GSM Management'

Nov 30, 2025

* Key discussions include the safety and efficacy of low-dose local vaginal estrogen, the importance of a patient-centered, shared decision-making approach, and clear consensus on when to use various therapies.

The new interdisciplinary guidelines for the Genitourinary Syndrome of Menopause (GSM) represent a critical, evidence-based advancement in women's health. Host Rachel S. Rubin, MD, is joined by co-chairs Melissa Kaufman, MD, PhD, and Una Lee, MD, to discuss the impact, scope, and key recommendations of this landmark...

• madman
• menopause; gsm; diagnosis/treatment
• Replies: 0
• Forum: HRT in Women